RainDance Technologies Secures $35M in Debt Financing to Support Expansion | GenomeWeb

NEW YORK (GenomeWeb News) – RainDance Technologies said today that it has closed a structured debt financing with Capital Royalty Partners, providing it with up to $35 million to support the commercial expansion of its digital PCR and targeted DNA sequencing products.

RainDance CEO Roopom Banerjee noted in an interview with GenomeWeb Daily News that the new financing comes at a time of "significant acceleration across every facet" of the company's business – particularly its recently launched RainDrop droplet-based digital PCR platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.